China · Delayed Price · Currency is CNY Boai NKY Medical Holdings Statistics
Total Valuation
SHE:300109 has a market cap or net worth of CNY 8.05 billion. The enterprise value is 8.03 billion.
| Market Cap | 8.05B |
| Enterprise Value | 8.03B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
SHE:300109 has 576.86 million shares outstanding. The number of shares has increased by 1.81% in one year.
| Current Share Class | 576.86M |
| Shares Outstanding | 576.86M |
| Shares Change (YoY) | +1.81% |
| Shares Change (QoQ) | -1.23% |
| Owned by Insiders (%) | 20.22% |
| Owned by Institutions (%) | 3.64% |
| Float | 460.23M |
Valuation Ratios
The trailing PE ratio is 54.36.
| PE Ratio | 54.36 |
| Forward PE | n/a |
| PS Ratio | 6.64 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | 43.08 |
| P/OCF Ratio | 22.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.83, with an EV/FCF ratio of 42.96.
| EV / Earnings | 52.78 |
| EV / Sales | 6.62 |
| EV / EBITDA | 22.83 |
| EV / EBIT | 31.09 |
| EV / FCF | 42.96 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.81 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 2.96 |
| Interest Coverage | 34.05 |
Financial Efficiency
Return on equity (ROE) is 4.24% and return on invested capital (ROIC) is 6.26%.
| Return on Equity (ROE) | 4.24% |
| Return on Assets (ROA) | 3.60% |
| Return on Invested Capital (ROIC) | 6.26% |
| Return on Capital Employed (ROCE) | 7.35% |
| Weighted Average Cost of Capital (WACC) | 5.38% |
| Revenue Per Employee | 1.02M |
| Profits Per Employee | 128,281 |
| Employee Count | 1,186 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, SHE:300109 has paid 36.08 million in taxes.
| Income Tax | 36.08M |
| Effective Tax Rate | 19.42% |
Stock Price Statistics
The stock price has decreased by -10.32% in the last 52 weeks. The beta is 0.26, so SHE:300109's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -10.32% |
| 50-Day Moving Average | 14.05 |
| 200-Day Moving Average | 14.83 |
| Relative Strength Index (RSI) | 47.30 |
| Average Volume (20 Days) | 25,157,864 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300109 had revenue of CNY 1.21 billion and earned 152.14 million in profits. Earnings per share was 0.26.
| Revenue | 1.21B |
| Gross Profit | 528.84M |
| Operating Income | 258.29M |
| Pretax Income | 185.76M |
| Net Income | 152.14M |
| EBITDA | 348.45M |
| EBIT | 258.29M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 547.15 million in cash and 552.34 million in debt, with a net cash position of -5.18 million or -0.01 per share.
| Cash & Cash Equivalents | 547.15M |
| Total Debt | 552.34M |
| Net Cash | -5.18M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 3.32B |
| Book Value Per Share | 5.67 |
| Working Capital | 624.13M |
Cash Flow
In the last 12 months, operating cash flow was 363.98 million and capital expenditures -177.07 million, giving a free cash flow of 186.91 million.
| Operating Cash Flow | 363.98M |
| Capital Expenditures | -177.07M |
| Depreciation & Amortization | 90.16M |
| Net Borrowing | 9.75M |
| Free Cash Flow | 186.91M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 43.63%, with operating and profit margins of 21.31% and 12.55%.
| Gross Margin | 43.63% |
| Operating Margin | 21.31% |
| Pretax Margin | 15.32% |
| Profit Margin | 12.55% |
| EBITDA Margin | 28.75% |
| EBIT Margin | 21.31% |
| FCF Margin | 15.42% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | -3.73% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 146.57% |
| Buyback Yield | -1.81% |
| Shareholder Yield | -0.61% |
| Earnings Yield | 1.89% |
| FCF Yield | 2.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 23, 2026. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 23, 2026 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |